A PD-1-specific toxin suppresses autoimmunity

Depletion of PD-1-positive cells ameliorates autoimmune disease

(2019) Peng Zhao et al.   Nature Biomedical Engineering

FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosis

(2018) Manolo Sambucci et al.   Scientific Reports

Fundamental Mechanisms of Immune Checkpoint Blockade Therapy

(2018) Spencer C. Wei et al.   Cancer Discovery

Programmed Death-1 Culls Peripheral Accumulation of High-Affinity Autoreactive CD4 T Cells to Protect against Autoimmunity

(2016) Tony T. Jiang et al.   Cell Reports

Disease-modifying treatments for multiple sclerosis - a review of approved medications

(2015) Ø. Torkildsen et al.   EUROPEAN JOURNAL OF NEUROLOGY

Multiple Sclerosis: Current and Emerging Disease-Modifying Therapies and Treatment Strategies

(2014) Dean M. Wingerchuk et al.   MAYO CLINIC PROCEEDINGS

Using EAE to better understand principles of immune function and autoimmune pathology

(2013) Manu Rangachari et al.   JOURNAL OF AUTOIMMUNITY

Immune status following alemtuzumab treatment in human CD52 transgenic mice

(2013) Michael J. Turner et al.   JOURNAL OF NEUROIMMUNOLOGY

A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application

(2013) Taku Okazaki et al.   NATURE IMMUNOLOGY

The PD-1 pathway in tolerance and autoimmunity

(2010) Loise M. Francisco et al.   IMMUNOLOGICAL REVIEWS